Patients The NHS risk crisis: The failure of risk in a complex health... *Disclaimer: The views and opinions expressed here are the author’s own and do not necessarily reflect those of pharmaphorum or its editorial staff.
Oncology ASCO 2026: Chinese firms take a front seat in oncology, with... Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.